These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 19608273
1. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. Nagel S, Venturini L, Meyer C, Kaufmann M, Scherr M, Drexler HG, MacLeod RA. Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273 [Abstract] [Full Text] [Related]
2. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Baer R. Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619 [Abstract] [Full Text] [Related]
3. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. McCormack MP, Shields BJ, Jackson JT, Nasa C, Shi W, Slater NJ, Tremblay CS, Rabbitts TH, Curtis DJ. Blood; 2013 Sep 19; 122(12):2093-103. PubMed ID: 23926305 [Abstract] [Full Text] [Related]
4. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia]. Meng YS, Wei R, Ai GW, Meng XQ, Zhang YX. Zhonghua Yi Xue Za Zhi; 2009 Apr 07; 89(13):890-3. PubMed ID: 19671288 [Abstract] [Full Text] [Related]
5. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes. San-Marina S, Han Y, Suarez Saiz F, Trus MR, Minden MD. Biochim Biophys Acta; 2008 Mar 07; 1783(3):503-17. PubMed ID: 18160048 [Abstract] [Full Text] [Related]
6. [Expression of transcription factor LYL1 in leukemia and its possible role in leukemogenesis]. Meng YS, Zhang YX, Ai GW, Meng XQ, Liu W, Wei R, Jiang W. Zhonghua Xue Ye Xue Za Zhi; 2008 Nov 07; 29(11):749-52. PubMed ID: 19176012 [Abstract] [Full Text] [Related]
7. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements. Homminga I, Vuerhard MJ, Langerak AW, Buijs-Gladdines J, Pieters R, Meijerink JP. Haematologica; 2012 Feb 07; 97(2):258-61. PubMed ID: 22058201 [Abstract] [Full Text] [Related]
8. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. Deleuze V, El-Hajj R, Chalhoub E, Dohet C, Pinet V, Couttet P, Mathieu D. PLoS One; 2012 Feb 07; 7(7):e40484. PubMed ID: 22792348 [Abstract] [Full Text] [Related]
9. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression. San-Marina S, Han Y, Liu J, Minden MD. Biochim Biophys Acta; 2012 Feb 07; 1819(11-12):1164-72. PubMed ID: 23000483 [Abstract] [Full Text] [Related]
10. Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia. Meng YS, Khoury H, Dick JE, Minden MD. Leukemia; 2005 Nov 07; 19(11):1941-7. PubMed ID: 16094422 [Abstract] [Full Text] [Related]
11. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia. Nagel S, Venturini L, Meyer C, Kaufmann M, Scherr M, Drexler HG, Macleod RA. Leuk Lymphoma; 2011 Feb 07; 52(2):290-7. PubMed ID: 21261500 [Abstract] [Full Text] [Related]
12. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12. Ryan DP, Duncan JL, Lee C, Kuchel PW, Matthews JM. Proteins; 2008 Mar 07; 70(4):1461-74. PubMed ID: 17910069 [Abstract] [Full Text] [Related]
13. Concise review: Blood relatives: formation and regulation of hematopoietic stem cells by the basic helix-loop-helix transcription factors stem cell leukemia and lymphoblastic leukemia-derived sequence 1. Curtis DJ, Salmon JM, Pimanda JE. Stem Cells; 2012 Jun 07; 30(6):1053-8. PubMed ID: 22593015 [Abstract] [Full Text] [Related]
14. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity. Xia Y, Hwang LY, Cobb MH, Baer R. Oncogene; 1994 May 07; 9(5):1437-46. PubMed ID: 8152805 [Abstract] [Full Text] [Related]
15. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia. Tan SH, Yam AW, Lawton LN, Wong RW, Young RA, Look AT, Sanda T. Leukemia; 2016 Apr 07; 30(4):959-62. PubMed ID: 26202930 [No Abstract] [Full Text] [Related]
16. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells. Cardoso BA, de Almeida SF, Laranjeira AB, Carmo-Fonseca M, Yunes JA, Coffer PJ, Barata JT. Leukemia; 2011 Oct 07; 25(10):1578-86. PubMed ID: 21647153 [Abstract] [Full Text] [Related]
17. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G. Genes Chromosomes Cancer; 2009 Dec 07; 48(12):1069-82. PubMed ID: 19760605 [Abstract] [Full Text] [Related]
18. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia. Correia NC, Melão A, Póvoa V, Sarmento L, Gómez de Cedrón M, Malumbres M, Enguita FJ, Barata JT. Oncotarget; 2016 Feb 16; 7(7):8268-81. PubMed ID: 26882564 [Abstract] [Full Text] [Related]
19. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation. Hofmann TJ, Cole MD. Oncogene; 1996 Aug 01; 13(3):617-24. PubMed ID: 8760303 [Abstract] [Full Text] [Related]
20. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis]. Gerby B, Armstrong F, Brunet de la Grange P, Calvo J, Ballerini P, Pflumio F. Ann Pathol; 2008 Nov 01; 28 Spec No 1(1):S28-9. PubMed ID: 18984291 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]